12:00 AM
 | 
Feb 23, 2009
 |  BC Week In Review  |  Company News  |  Other News

CuraGen cancer news

CuraGen retained JSB-Partners to identify potential buyers for CuraGen's lead candidate CR011-vcMMAE and plans to retain an investment bank to review other alternatives, including acquisitions or a sale of the...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >